← Evidence map

ReviewTherapeutics and clinical risk management2017

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide.

Mario Cozzolino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28615947